These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38619025)

  • 21. Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B-cell depleted patients with persistent COVID-19.
    Inbar T; Dann EJ; Kerner O; Stern A
    Transfusion; 2024 Mar; 64(3):443-448. PubMed ID: 38327238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective.
    Kanj S; Al-Omari B
    Viruses; 2021 May; 13(5):. PubMed ID: 34066932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
    JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.
    Kasten MJ; Lahr BD; Parisapogu A; Yetmar ZA; O'Horo JC; Orenstein R; Moreno Franco P; Razonable RR; Vergidis P; Shah AS; Enzler MJ; Inwards DJ; Bauer PR
    Sci Rep; 2023 Dec; 13(1):21249. PubMed ID: 38040756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transfusion of convalescent plasma from patients with COVID -19].
    Galván CA; Toribio-Dionicio C; Álvarez-Ángeles M; Alama-Bazán O; Sánchez-Ramírez L
    Rev Peru Med Exp Salud Publica; 2020; 37(4):746-754. PubMed ID: 33566918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus Disease-2019 in the Immunocompromised Host.
    Bertini CD; Khawaja F; Sheshadri A
    Infect Dis Clin North Am; 2024 Mar; 38(1):213-228. PubMed ID: 38280765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
    Magyari F; Pinczés LI; Páyer E; Farkas K; Ujfalusi S; Diószegi Á; Sik M; Simon Z; Nagy G; Hevessy Z; Nagy B; Illés Á
    Ann Hematol; 2022 Oct; 101(10):2337-2345. PubMed ID: 35836007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus Disease-2019 in the Immunocompromised Host.
    Bertini CD; Khawaja F; Sheshadri A
    Clin Chest Med; 2023 Jun; 44(2):395-406. PubMed ID: 37085228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
    Levy I; Lavi A; Zimran E; Grisariu S; Aumann S; Itchaki G; Berger T; Raanani P; Harel R; Aviv A; Lavi N; Zuckerman T; Shvidel L; Jarchowsky O; Ellis M; Herzog Tzarfati K; Koren-Michowitz M; Sherf Y; Levi I; Sofer O; Shpilberg O; Dally N; Suriu C; Braester A; Ben Barouch S; Leiba M; Goldstein D; Sarid N; Yeganeh S; Halloun J; Mittelman M; Tadmor T
    Leuk Lymphoma; 2021 Dec; 62(14):3384-3393. PubMed ID: 34405767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics.
    Aviani JK; Halim D; Soeroto AY; Achmad TH; Djuwantono T
    Rev Med Virol; 2021 Nov; 31(6):e2225. PubMed ID: 33621405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
    Lanza F; Monaco F; Ciceri F; Cairoli R; Sacchi MV; Guidetti A; Marchetti M; Massaia M; Arcaini L; Krampera M; Mohamed S; Gherlinzoni F; Mecucci C; Gentile M; Romano I; Venditti A; Ruggeri M; Ferrero D; Coviello E; Fabbri E; Corradini P; Passamonti F
    Hematol Oncol; 2022 Dec; 40(5):857-863. PubMed ID: 35932208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
    Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ;
    mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].
    Chen S; Lu C; Li P; Wang L; Wang H; Yang Q; Chen-Li Y; Li J; Ma H; Sang Q; Xu L; Li J; Zhang Y; Kang Y; Xing L; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1293-1298. PubMed ID: 33463485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19.
    Biernat MM; Kolasińska A; Kwiatkowski J; Urbaniak-Kujda D; Biernat P; Janocha-Litwin J; Szymczyk-Nużka M; Bursy D; Kalicińska E; Simon K; Mazur G; Wróbel T
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33800528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of convalescent plasma transfusion on outcomes of coronavirus disease 2019: a meta-analysis with trial sequential analysis.
    Hakim SM; Chikhouni GMA; Ammar MA; Amer AM
    J Anesth; 2023 Jun; 37(3):451-464. PubMed ID: 36811668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
    Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
    J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
    Dai W; Wu J; Li T; Shen J; Pang R; Luo T; Guo Y; Yang Y; Zhao J; Zhang M; Li N; Han Y; Wu Q; Li W; Xia X
    J Med Virol; 2021 Apr; 93(4):2321-2331. PubMed ID: 33289151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.